Raphael Pharmaceutical Inc (RAPH)
1.54
+0.54
(+54.00%)
USD |
OTCM |
May 21, 11:04
Raphael Pharmaceutical Cash from Operations (TTM): -0.976M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.976M |
| December 31, 2023 | -1.203M |
| September 30, 2023 | -1.392M |
| June 30, 2023 | -1.043M |
| March 31, 2023 | -1.076M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.759M |
| September 30, 2022 | -1.185M |
| June 30, 2022 | -1.314M |
| March 31, 2022 | -1.371M |
| December 31, 2021 | -1.418M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.418M
Minimum
Dec 2021
-0.759M
Maximum
Dec 2022
-1.174M
Average
-1.194M
Median
Cash from Operations (TTM) Benchmarks
| InspireMD Inc | -16.61M |
| Pluri Inc | -16.60M |
| BiomX Inc | -21.29M |
| Alpha Tau Medical Ltd | -- |
| Holdco Nuvo Group DG Ltd | -14.96M |